These findings suggested that CD39 might be involved in shaping the cytokine milieu and neutrophil effector functions in TB patients, potentially influencing the balance between protective Th1 immunity and detrimental immunopathology driven by Th2, Th17, regulatory cytokines and neutrophil-mediated inflammation. Here, ENTPD1 is linked to tuberculosis.